Please cite this article as: LIU YQ, LI DD, CHAI M, CONG HL, CONG XQ, DAI J, DU RP, GAO M, GUO JC, GUO YQ, HONG XJ, HUANG RC, JIA FS, LI JY, LI Q, LIU JM, LIU XP, LIU YG, NIE HG, SHAO B, SHEN XY, SONG HQ, SONG YJ, WANG LJ, WANG S, WU DM, XIA J, YANG ZY, YU HY, ZHANG H, ZHANG TM, ZHAO JY, ZHAO LC, ZHENG MQ, CHEN YD. Real world effectiveness of PCSK-9 inhibitors combined with statins versus statins-based therapy among patients with very high risk of atherosclerotic cardiovascular disease in China (RWE-PCSK study). J Geriatr Cardiol 2021; 18(4): 261−270. DOI: 10.11909/j.issn.1671-5411.2021.04.005.
Citation:
|
Please cite this article as: LIU YQ, LI DD, CHAI M, CONG HL, CONG XQ, DAI J, DU RP, GAO M, GUO JC, GUO YQ, HONG XJ, HUANG RC, JIA FS, LI JY, LI Q, LIU JM, LIU XP, LIU YG, NIE HG, SHAO B, SHEN XY, SONG HQ, SONG YJ, WANG LJ, WANG S, WU DM, XIA J, YANG ZY, YU HY, ZHANG H, ZHANG TM, ZHAO JY, ZHAO LC, ZHENG MQ, CHEN YD. Real world effectiveness of PCSK-9 inhibitors combined with statins versus statins-based therapy among patients with very high risk of atherosclerotic cardiovascular disease in China (RWE-PCSK study). J Geriatr Cardiol 2021; 18(4): 261−270. DOI: 10.11909/j.issn.1671-5411.2021.04.005.
|
Please cite this article as: LIU YQ, LI DD, CHAI M, CONG HL, CONG XQ, DAI J, DU RP, GAO M, GUO JC, GUO YQ, HONG XJ, HUANG RC, JIA FS, LI JY, LI Q, LIU JM, LIU XP, LIU YG, NIE HG, SHAO B, SHEN XY, SONG HQ, SONG YJ, WANG LJ, WANG S, WU DM, XIA J, YANG ZY, YU HY, ZHANG H, ZHANG TM, ZHAO JY, ZHAO LC, ZHENG MQ, CHEN YD. Real world effectiveness of PCSK-9 inhibitors combined with statins versus statins-based therapy among patients with very high risk of atherosclerotic cardiovascular disease in China (RWE-PCSK study). J Geriatr Cardiol 2021; 18(4): 261−270. DOI: 10.11909/j.issn.1671-5411.2021.04.005.
Citation:
|
Please cite this article as: LIU YQ, LI DD, CHAI M, CONG HL, CONG XQ, DAI J, DU RP, GAO M, GUO JC, GUO YQ, HONG XJ, HUANG RC, JIA FS, LI JY, LI Q, LIU JM, LIU XP, LIU YG, NIE HG, SHAO B, SHEN XY, SONG HQ, SONG YJ, WANG LJ, WANG S, WU DM, XIA J, YANG ZY, YU HY, ZHANG H, ZHANG TM, ZHAO JY, ZHAO LC, ZHENG MQ, CHEN YD. Real world effectiveness of PCSK-9 inhibitors combined with statins versus statins-based therapy among patients with very high risk of atherosclerotic cardiovascular disease in China (RWE-PCSK study). J Geriatr Cardiol 2021; 18(4): 261−270. DOI: 10.11909/j.issn.1671-5411.2021.04.005.
|